Skip to content
lifestyle.buyersdesire.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Medicenna Therapeutics Corp.
Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026
March 18, 2026
Medicenna Therapeutics Announces Participation in Upcoming Conferences
March 11, 2026
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
March 10, 2026
Medicenna Announces Changes to Board Composition
March 10, 2026
←
Previous Page
1
2